CAS 9050-31-1PubChem CID 57469
Imiquimod
Imiquimod is an imidazoquinoline fused [4,5-c] carrying isobutyl and amino substituents at N-1 and C-4 respectively. A prescription medication, it acts as an immune response modifier and is used to treat genital warts, superficial basal cell carcinoma, and actinic keratosis. It has a role as an antineoplastic agent and an interferon inducer.
— ChEBI
- IUPAC name
- 1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine
- Molecular formula
- C14H16N4
- Molecular weight
- 240.30 g/mol
- Exact mass
- 240.137496527 Da
- XLogP3
- 2.6
- Topological polar surface area
- 56.7 Ų
- Hydrogen-bond donors
- 1
- Hydrogen-bond acceptors
- 3
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
Aldara1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amineZyclara1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine4-Amino-1-isobutyl-1H-imidazo[4,5-c]quinolineR-837R 8374-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline
16 more reported names
S-26308TMX-101S 26308ImiquimodumNSC-369100NSC-759651P1QW714R7MTMX 1011H-Imidazo(4,5-c)quinolin-4-amine, 1-(2-methylpropyl)-R8371H-Imidazo[4,5-c]quinolin-4-amine, 1-(2-methylpropyl)-CHEBI:367041-isobutyl-1H-imidazo(4,5-c)quinolin-4-amine1-(2-methylpropyl)-1H-imidazo(4,5-c)quinolin-4-amineRefChem:57767D06BB10
External database identifiers
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.